Mahaffey, K
Sixteen participants spent five nights in a sleep lab, with the first night for adaptation and the second for baseline measurements
A 2-year clinical study in 1991 used low-dose IM DFO (125 mg b.i.d., 5 days/week) in AD patients, which showed a significantly slower (50%) decline in daily living skills, suggesting a disease-slowing effect (Percy et al., 2011)
Slowing aging has never been simpler Explore our treatments Browse our offerings or tell us about your health goals
IV therapy may alleviate severe symptoms and improve overall skin health, helping you feel and look your best
Xu X, Zhang H, Meng K, Cai H, Liu W, Song L, et al